Coherus Oncology (NASDAQ:CHRS) Q3 2026 Earnings Call
Coherus Oncology (NASDAQ:CHRS) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.

- Company
- Coherus Oncology, Inc. (NASDAQ:CHRS)
- Period
- Q3 2026 earnings call
- Date
- Mon, Nov 9, 2026, 5:00 PM ET
On 6ix: 6ix.com/event/coherus-oncology-inc-chrs-q3-2026-earnings-call
Latest news releases
- NASDAQ:CHRS — Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development · Wed, Oct 28, 2026
- NASDAQ:CHRS — Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development · Wed, Oct 28, 2026